vs
Side-by-side financial comparison of ON24 INC. (ONTF) and ROCKWELL MEDICAL, INC. (RMTI). Click either name above to swap in a different company.
ON24 INC. is the larger business by last-quarter revenue ($34.6M vs $18.3M, roughly 1.9× ROCKWELL MEDICAL, INC.). ROCKWELL MEDICAL, INC. runs the higher net margin — -3.0% vs -18.8%, a 15.7% gap on every dollar of revenue. On growth, ON24 INC. posted the faster year-over-year revenue change (-5.6% vs -25.6%). ROCKWELL MEDICAL, INC. produced more free cash flow last quarter ($2.2M vs $-2.2M). Over the past eight quarters, ON24 INC.'s revenue compounded faster (-4.2% CAGR vs -10.1%).
ON24 Inc., a San Francisco-based company, is a cloud-based platform that develops and sells web-based webinar, virtual conferencing, content hub, and landing page applications as a service for marketing and sales teams in B2B organizations. In 2023 it expanded its offerings to include generative AI services.
Rockwell Medical Inc. is a publicly traded pharmaceutical company based in Wixom, Michigan and founded in 1996 that focuses on development and commercialization of treatments against diseases such as end-stage renal disease (ESRD) and chronic kidney disease (CKD).
ONTF vs RMTI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $34.6M | $18.3M |
| Net Profit | $-6.5M | $-554.0K |
| Gross Margin | 74.9% | 21.1% |
| Operating Margin | -23.5% | -2.2% |
| Net Margin | -18.8% | -3.0% |
| Revenue YoY | -5.6% | -25.6% |
| Net Profit YoY | 26.8% | 26.7% |
| EPS (diluted) | $-0.15 | $-0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $34.6M | $18.3M | ||
| Q3 25 | $34.6M | $15.9M | ||
| Q2 25 | $35.3M | $16.1M | ||
| Q1 25 | $34.7M | $18.9M | ||
| Q4 24 | $36.7M | $24.7M | ||
| Q3 24 | $36.3M | $28.3M | ||
| Q2 24 | $37.3M | $25.8M | ||
| Q1 24 | $37.7M | $22.7M |
| Q4 25 | $-6.5M | $-554.0K | ||
| Q3 25 | $-6.4M | $-1.8M | ||
| Q2 25 | $-7.3M | $-1.5M | ||
| Q1 25 | $-8.7M | $-1.5M | ||
| Q4 24 | $-8.9M | $-756.0K | ||
| Q3 24 | $-11.4M | $1.7M | ||
| Q2 24 | $-11.2M | $343.0K | ||
| Q1 24 | $-10.7M | $-1.7M |
| Q4 25 | 74.9% | 21.1% | ||
| Q3 25 | 74.7% | 14.3% | ||
| Q2 25 | 75.1% | 15.6% | ||
| Q1 25 | 73.8% | 16.1% | ||
| Q4 24 | 74.5% | 14.7% | ||
| Q3 24 | 74.3% | 22.0% | ||
| Q2 24 | 74.5% | 17.6% | ||
| Q1 24 | 74.1% | 13.5% |
| Q4 25 | -23.5% | -2.2% | ||
| Q3 25 | -23.1% | -9.9% | ||
| Q2 25 | -26.0% | -8.4% | ||
| Q1 25 | -30.1% | -7.2% | ||
| Q4 24 | -32.1% | -2.1% | ||
| Q3 24 | -36.7% | 6.8% | ||
| Q2 24 | -35.0% | 2.0% | ||
| Q1 24 | -33.1% | -5.8% |
| Q4 25 | -18.8% | -3.0% | ||
| Q3 25 | -18.4% | -11.0% | ||
| Q2 25 | -20.6% | -9.3% | ||
| Q1 25 | -25.1% | -8.0% | ||
| Q4 24 | -24.2% | -3.1% | ||
| Q3 24 | -31.4% | 5.9% | ||
| Q2 24 | -29.9% | 1.3% | ||
| Q1 24 | -28.4% | -7.6% |
| Q4 25 | $-0.15 | $-0.01 | ||
| Q3 25 | $-0.15 | $-0.05 | ||
| Q2 25 | $-0.17 | $-0.05 | ||
| Q1 25 | $-0.21 | $-0.04 | ||
| Q4 24 | $-0.21 | $-0.02 | ||
| Q3 24 | $-0.27 | $0.04 | ||
| Q2 24 | $-0.27 | $0.01 | ||
| Q1 24 | $-0.26 | $-0.06 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $37.0M | $10.7M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $139.4M | $37.0M |
| Total Assets | $228.4M | $57.1M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $37.0M | $10.7M | ||
| Q3 25 | $47.2M | $13.6M | ||
| Q2 25 | $37.7M | $12.5M | ||
| Q1 25 | $26.8M | $11.4M | ||
| Q4 24 | $14.9M | $15.7M | ||
| Q3 24 | $11.0M | $12.3M | ||
| Q2 24 | $15.5M | $11.9M | ||
| Q1 24 | $18.3M | $6.6M |
| Q4 25 | $139.4M | $37.0M | ||
| Q3 25 | $144.3M | $37.0M | ||
| Q2 25 | $150.0M | $30.4M | ||
| Q1 25 | $153.7M | $31.5M | ||
| Q4 24 | $159.4M | $32.6M | ||
| Q3 24 | $164.9M | $29.1M | ||
| Q2 24 | $170.8M | $23.5M | ||
| Q1 24 | $174.4M | $20.6M |
| Q4 25 | $228.4M | $57.1M | ||
| Q3 25 | $224.8M | $57.5M | ||
| Q2 25 | $235.1M | $52.6M | ||
| Q1 25 | $245.8M | $54.0M | ||
| Q4 24 | $251.0M | $59.2M | ||
| Q3 24 | $250.9M | $57.1M | ||
| Q2 24 | $259.0M | $53.0M | ||
| Q1 24 | $269.2M | $50.7M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $-1.1M | $2.3M |
| Free Cash FlowOCF − Capex | $-2.2M | $2.2M |
| FCF MarginFCF / Revenue | -6.4% | 12.0% |
| Capex IntensityCapex / Revenue | 3.3% | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $4.0M | $-1.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.1M | $2.3M | ||
| Q3 25 | $2.5M | $-1.3M | ||
| Q2 25 | $2.6M | $1.8M | ||
| Q1 25 | $3.4M | $-3.5M | ||
| Q4 24 | $985.0K | $865.0K | ||
| Q3 24 | $295.0K | $4.3M | ||
| Q2 24 | $1.4M | $1.4M | ||
| Q1 24 | $2.1M | $-2.4M |
| Q4 25 | $-2.2M | $2.2M | ||
| Q3 25 | $2.2M | $-1.5M | ||
| Q2 25 | $2.1M | $1.7M | ||
| Q1 25 | $1.9M | $-3.5M | ||
| Q4 24 | $424.0K | $470.0K | ||
| Q3 24 | $143.0K | $4.1M | ||
| Q2 24 | $898.0K | $1.2M | ||
| Q1 24 | $1.1M | $-2.5M |
| Q4 25 | -6.4% | 12.0% | ||
| Q3 25 | 6.2% | -9.6% | ||
| Q2 25 | 5.9% | 10.5% | ||
| Q1 25 | 5.6% | -18.8% | ||
| Q4 24 | 1.2% | 1.9% | ||
| Q3 24 | 0.4% | 14.4% | ||
| Q2 24 | 2.4% | 4.5% | ||
| Q1 24 | 2.9% | -11.1% |
| Q4 25 | 3.3% | 0.5% | ||
| Q3 25 | 1.1% | 1.4% | ||
| Q2 25 | 1.4% | 1.0% | ||
| Q1 25 | 4.2% | 0.3% | ||
| Q4 24 | 1.5% | 1.6% | ||
| Q3 24 | 0.4% | 0.7% | ||
| Q2 24 | 1.3% | 1.1% | ||
| Q1 24 | 2.8% | 0.6% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 2.57× | ||
| Q2 24 | — | 4.20× | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ONTF
Segment breakdown not available.
RMTI
| US | $15.9M | 87% |
| Non Us | $2.4M | 13% |